Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Hamill John P.

SEC-identified person · CIK 1716213 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Aprea Therapeutics, Inc. APRE SrVP/CFO/Prin. Fin&Acctg. Off filed 2023–2026
Windtree Therapeutics INC /DE/ dsco SVP & CFO filed 2020–2022
Trevena INC TRVN VP Fin,Princ Fin&Acct Officer filed 2018–2019
Cellectar Biosciences, Inc. clrB Interim CFO filed 2017–2017

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.